{"action":"published","release":{"url":"https://api.github.com/repos/sigven/cpsr/releases/13856655","assets_url":"https://api.github.com/repos/sigven/cpsr/releases/13856655/assets","upload_url":"https://uploads.github.com/repos/sigven/cpsr/releases/13856655/assets{?name,label}","html_url":"https://github.com/sigven/cpsr/releases/tag/v.0.2.0","id":13856655,"node_id":"MDc6UmVsZWFzZTEzODU2NjU1","tag_name":"v.0.2.0","target_commitish":"master","name":"ACMG classification adjustments","draft":false,"author":{"login":"sigven","id":1872622,"node_id":"MDQ6VXNlcjE4NzI2MjI=","avatar_url":"https://avatars2.githubusercontent.com/u/1872622?v=4","gravatar_id":"","url":"https://api.github.com/users/sigven","html_url":"https://github.com/sigven","followers_url":"https://api.github.com/users/sigven/followers","following_url":"https://api.github.com/users/sigven/following{/other_user}","gists_url":"https://api.github.com/users/sigven/gists{/gist_id}","starred_url":"https://api.github.com/users/sigven/starred{/owner}{/repo}","subscriptions_url":"https://api.github.com/users/sigven/subscriptions","organizations_url":"https://api.github.com/users/sigven/orgs","repos_url":"https://api.github.com/users/sigven/repos","events_url":"https://api.github.com/users/sigven/events{/privacy}","received_events_url":"https://api.github.com/users/sigven/received_events","type":"User","site_admin":false},"prerelease":true,"created_at":"2018-11-06T15:54:03Z","published_at":"2018-11-06T15:56:29Z","assets":[],"tarball_url":"https://api.github.com/repos/sigven/cpsr/tarball/v.0.2.0","zipball_url":"https://api.github.com/repos/sigven/cpsr/zipball/v.0.2.0","body":"* Mechanisms of disease for cancer susceptibility genes (GoF vs. LoF) retrieved from [Maxwell et al., *Am J Hum Genet*, 2016](https://www.ncbi.nlm.nih.gov/pubmed/27153395)\r\n* Exceptions for HFE/SERPINA1 wrt. high population MAF (*BA1*)\r\n* Threshold for genes with \"primarily truncations\" set to 90% pathogenic truncations (*BP1*)\r\n* Consider only pathogenic ClinVar variants (not likely pathogenic) when checking for novel peptide changes at pathogenic loci (*PS1*/*PM5*)"}}
{"actor":{"display_login":"sigven"}}